The roles of adenosine and adenosine receptors in bone remodeling

Frontiers in Bioscience - Elite

Volumn 3 E, Issue 3, 2011, Pages 888-895

  He, Wenjie ^a   Cronstein, Bruce ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine; Adenosine receptors; Bone; Osteoblast; Osteoclast; Review

Indexed keywords

6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; ADENOSINE; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; INTERLEUKIN 6; METHOTREXATE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PURINE NUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BONE DENSITY; BONE DESTRUCTION; BONE MASS; BONE METABOLISM; BONE REMODELING; BONE STRUCTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FRACTURE; HOMEOSTASIS; KNEE OSTEOARTHRITIS; LOW DRUG DOSE; MONOCYTE MACROPHAGE PRECURSOR CELL; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PURINE METABOLISM; RHEUMATOID ARTHRITIS; BIOSYNTHESIS; CYTOLOGY; DRUG EFFECT; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

MUS;

ADENOSINE; BONE REMODELING; HOMEOSTASIS; HUMANS; OSTEOBLASTS; OSTEOCLASTS; RECEPTORS, PURINERGIC P1;

EID: 80053579432     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Brian R. Wong, Jaerang Rho, Joseph Arron, Elizabeth Robinson, Jason Orlinick, Moses Chao, Sergey Kalachikovi, Eftihia Cayanii, Frederick S. Bartlett III, Wayne N. Frankel, Soo Young Lee and Yongwon Cho: TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun. n-terminal kinase in T cells. J Biol Chem 272, 25190-25194 (1997) (Pubitemid 27415705)
2. Dirk M. Anderson, Eugene Marakovsky, William L. Billingsley, William C. Dougall, Mark E. Tometsko, Eileen R. Roux, Mark C. Teepe, Robert F. Du Bose, Davide Cosman and Laurent Galibert: A homologue of the TNF receptor and its ligand enhance T-cell growth and dendriticcell function. Nature 390, 175-179 (1997) (Pubitemid 27507987)
3. Hisataka Yasuda, Nobuyuki Shima, Nobuaki Nakagawa, Kyoji Yamaguchi, Masahiko Kinosaki, Shin-Ichi Mochizuki, Akihiro Tomoyasu, Kazuki Yano, Masaaki Goto, Akihiko Murakami, Eisuke Tsuda, Tomonori Morinaga, Kanji Higashio, Nobuyuki Udagawa, Naoyuki Takahashi and Tatsuo Suda: Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesisinhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95, 3597-35602 (1998)
4. Young-Yun Kong, Hiroki Yoshida, Ildiko Sarosi, Hong-Lin Tan, Emma Timms, Casey Capparelli, Sean Morony, Antonio J. Oliveira-dos-Santos, Gwyneth Van, Annick Itie, Wilson Khoo, Andrew Wakeham, Colin R. Dunstan, David L. Lacey, Tak W. Mak, William J. Boyle and Josef M. Penninger: OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315-323 (1999)
5. D. L. Lacey, E. Timms, H.-L. Tan, M. J. Kelley, C. R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, H. Hsu, J. Sullivan, N. Hawkins, E. Davy, C. Capparelli, A. Eli, Y.-X. Qian, S. Kaufman, I. Sarosi, V. Shalhoub, G. Senaldi, J. Guo, J. Delaney and W. J. Boyle: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176 (1998) (Pubitemid 28180851)
6. Nobuaki Nakagawa, Masahiko Kinosaki, Kyoji Yamaguchi, Nobuyuki Shima, Hisataka Yasuda, Kazuki Yano, Tomonori Morinaga and Kanji Higashio: RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem Biophys Res Commun 253, 395-400 (1998) (Pubitemid 29026714)
7. Hailing Hsu, David L. Lacey, Colin R. Dunstan, Irina Solovyev, Anne Colombero, Emma Timms, Hong-Lin Tan, Gary Elliott, Michael J. Kelley, Ildiko Sarosi, Ling Wang, Xing-Zhong Xia, Robin Elliott, Laura Chiu, Tabitha Black, Sheila Scully, Casey Capparelli, Sean Morony, Grant Shimamoto, Michael B. Bass and William J. Boyle: Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 96, 3540-3545 (1999) (Pubitemid 29168945)
8. Ji Li, Ildiko Sarosi, Xiao-Qiang Yan, Sean Morony, Casey Capparelli, Hong-Lin Tan, Susan McCabe, Robin Elliott, Sheila Scully, Gwyneth Van, Stephen Kaufman, Shao-Chieh Juan, Yu Sun, John Tarpley, Laura Martin, Kathleen Christensen, James McCabe, Paul Kostenuik, Hailing Hsu, Frederick Fletcher, Colin R. Dunstan, David L. Lacey and William J. Boyle: RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA 97, 1566-1571 (2000) (Pubitemid 30118482)
9. Hisataka Yasuda, Nobuyuki Shima, Nobuaki Nakagawa, Shin-Ichi Mochizuki, Kazuki Yano, Nobuaki Fujise, Yasushi Sato, Masaaki Goto, Kyoji Yamaguchi, Masayoshi Kuriyama, Takeshi Kanno, Akihiko Murakami, Eisuke Tsuda, Tomonori Morinaga and Kanji Higashio: Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139, 1329-1337 (1998) (Pubitemid 28510154)
10. Eisuke Tsuda, Masaaki Goto, Shin-ichi Mochizuki, Kazuki Yano, Fumie Kobayashi, Tomonori Morinaga and Kanji Higashio: Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 234, 137-142 (1997) (Pubitemid 27267548)
11. W. S. Simonet, D. L. Lacey, C. R. Dunstan, M. Kelley, M.-S. Chang, R. Lüthy, H. Q. Nguyen, S. Wooden, L. Bennett, T. Boone, G. Shimamoto, M. De Rose, R. Elliott, A. Colombero, H.-L. Tan, G. Trail, J. Sullivan, E. Davy, N. Bucay, L. Renshaw-Gegg, T. M. Hughes2, D. Hill, W. Pattison, P. Campbell, S. Sander, G. Van, J. Tarpley, P. Derby, R. Lee and W. J. Boyle: Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89, 309-319 (1997) (Pubitemid 27199902)
12. Nicole J. Horwood, Jan Elliott, T. John Martin and Matthew T. Gillespie: Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology 139, 4743-4746 (1998) (Pubitemid 28487795)
13. Masazumi Nagai and Nobuko Sato: Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation. Biochem Biophys Res Commun 257, 719-723 (1999) (Pubitemid 29301509)
14. Young-Yun Kong, Ulrich Feige, Iidiko Sarosi, Brad Bolon, Anna Tafuri, Sean Morony, Casey Capparelli, Ji Li, Robin Elliott, Susan McCabe, Thomas Wong, Giuseppe Campagnuolo, Erika Moran, Earl R. Bogoch, Gwyneth Van, Linh T. Nguyen, Pamela S. Ohashi, David L. Lacey, Eleanor Fish, William J. Boyle and Josef M. Penninger. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402, 304-309 (1999) (Pubitemid 129516268)
15. Paul Waterhouse, Josef M. Penninger, Emma Timms, Andrew Wakeham, Arda Shahinian, Kelvin P. Lee, Craig B. Thompson, Henrik Griesser, Tak W. Mak: Lymphoproliferative disorders with early lethality inmice deficient in Ctla-4. Science 270, 985-988 (1995)
16. Kojiro Sato, Ayako Suematsu, Kazuo Okamoto, Akira Yamaguchi, Yasuyuki Morishita, Yuho Kadono, Sakae Tanaka, Tatsuhiko Kodama, Shizuo Akira, Yoichiro Iwakura, Daniel J. Cua and Hiroshi Takayanagi: Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 203, 2673-2682 (2006) (Pubitemid 44833343)
17. Theodore J. Yun, Michelle D. Tallquist, Alexandra Aicher, Katherine L. Rafferty, Aaron J. Marshall, James J. Moon, Maria K. Ewings, Mariette Mohaupt, Susan W. Herring and Edward A. Clark. Osteoprotegerin, a crucial regulator of bonemetabolism, also regulates B cell development and function. J Immunol 166, 1482-1491 (2001) (Pubitemid 32114626)
18. Yuhao Gao, Francesco Grassi, Michaela Robbie Ryan, Masakazu Terauchi, Karen Page, Xiaoying Yang, Neale M. Weitzmann and Roberto Pacific: IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigendriven T cell activation. J Clin Invest 117, 122-132 (2007). (Pubitemid 46048459)
19. Hiroshi Takayanagi, Kouetsu Ogasawara, Shigeaki Hida, Tomoki Chiba, Shigeo Murata, Kojiro Sato, Akinori Takaoka, Taeko Yokochi, Hiromi Oda, Keiji Tanaka, Kozo Nakamura and Tadatsugu Taniguchi: T-cell-mediated regulation of osteoclastogenesis by signaling cross-talk between RANKL and IFN-γ. Nature 408, 600-605 (2000)
20. Régis Josien, Brian R. Wong, Hong-Li Li, Ralph M. Steinman and Yongwon Choi: TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J Immunol 162, 2562-2568 (1999) (Pubitemid 29309274)
21. Matthew S. Morrison, Luca Turin, Brian F. King, Geoffrey Burnstock and Timothy R. Arnett: ATP is a potent stimulator of the activation and formation of rodent osteoclasts. J Physiol 511, 495-500 (1998) (Pubitemid 28444617)
22. K. A. Buckley, R. A. Hipskind, A. Gartland, W. B. Bowler and J. A. Gallagher: Adenosine triphosphate stimulates human osteoclast activity via upregulation of osteoblast-expressed receptor activator of nuclear factorkappa B ligand. Bone 31, 582-590 (2002) (Pubitemid 35449700)
23. Astrid Hoebertz, Sajeda Meghji, Geoffrey Burnstock and Timothy R. Arnett: Extracellular ADP is a powerful osteolytic agent: evidence for signaling through the P2Y1 receptor on bone cells. FASEB J 15, 1139-1148 (2001) (Pubitemid 32436299)
24. J. Buchholz, F. X. Huber, P. J. Meeder, G. Muhr, G. K. Kreitz and L. Herzog: Detection of high-energy phosphates in cortical bone as an indicator of bone healing and remodelling: Use of a rabbit model. J Orthop Surg (Hong Kong) 12, 205-209 (2004) (Pubitemid 40435149)
25. K. A. Buckley, S. L. Golding, J. M. Rice, J. P. Dillon, J. A. Gallagher. Release and interconversion of P2 receptor agonists by human osteoblast-like cells. FASEB J 17, 1401-1410 (2003) (Pubitemid 36935655)
26. Damian C Genetos, Derik J Geist, Dawei Liu, Henry J Donahue and Randall L Duncan: Fluid shear-induced ATP secretion mediates postaglandin release in MC3T3-E1 osteoblasts. J Bone Miner Res 20, 41-49 (2005) (Pubitemid 41716217)
27. Bronwen A. J. Evans, Carole Elford, Annette Pexa, Karen Francis, Alis C Hughes, Andreas Deussen, and Jack Ham: Human osteoblast precursors produce extracellular adenosine, which modulates their secretion of IL-6 and osteoprotegerin. J Bone Miner Res 21, 228-236 (2006) (Pubitemid 43265288)
28. Bronwen A. J. Evans and Jack Ham: The role of adenosine in bone: an emerging concept. Immun Endoc Metab Agents in Med Chem 7, 322-327 (2007) (Pubitemid 47261624)
29. Frank Barry, Raymond Boynton, Mary Murphy and Joseph Zaia: The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells. Biochem Biophys Res Commun 289, 519-524 (2001) (Pubitemid 33141085)
30. Majid Katebi, Mansooreh Soleimani and Bruce N. Cronstein: Adenosine A2a receptors play an active role in mouse bone marrow-derived mesenchymal stem cell development. J Leukoc Biol 85, 438-444 (2009)
31. Joseph M. Russell, Graham S. Stephenson, Clare E. Yellowley and Hilary P. Benton: Adenosine inhibition of lipopolysaccharide-induced interleukin-6 secretion by the osteoblastic cell line MG-63. Calcif Tissue Int 81, 316-326 (2007) (Pubitemid 47498103)
32. 1Rs) play a critical role in osteoclast formation and function. FASEB J 24, 2325-2333 (2010)
33. 1 receptor-knockout mice. Arthritis Rheum 62, 534-541 (2010)
34. K. Varani, M. De Mattei, F. Vincenzi, S. Gessi, S. Merighi, A. Pellati, A. Ongaro, A. Caruso, R. Cadossi and P. A. Borea: Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields. Osteoarthritis Cargilage 16, 292-304 (2008) (Pubitemid 351309182)
35. Mitchell Koolpe, David Pearson and Hilary P. Benton: Expression of both P1 and P2 purine receptor genes by human articular chondrocytes and profile of ligandmediated prostaglandin E2 release. Arthritis Rheum 42, 258-267 (1999) (Pubitemid 29072842)
36. K. Varani, F. Vincenzi, A. Tosi, M. Targa, F. F. Masieri, A. Ongaro, M. De Mattei, L. Massari and P. A. Borea: Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes. Br J Pharmacol 160, 101-115 (2010)
37. Hilary P. Benton, Melinda H. MacDonald and Anthony M. Tesch: Effects of adenosine on bacterial lipopolysaccharide-and interleukin 1-induced nitric oxide release from equine articular chondrocytes. Am J Vet Res 63, 204-210 (2002)
38. D. Mistry, M. G. Chambers and R. M. Mason: The role of adenosine in chondrocyte death in murine osteoarthritis and in a murine chondrocyte cell line. Osteoarthritis Cartilage 14, 486-495 (2006)
39. David L. Boyle, Fereydoun G. Sajjadi and Gary S. Firestein: Inhibition of synoviocyte collagenase gene expression by adenosine receptor stimulation. Arthritis Rheum 39, 923-930 (1996) (Pubitemid 26182059)
40. Nguyen D. Khoa, Carmen M. Montesinos, Allison B. Reiss, David Delano, Nahel Awadallah and Bruce N. Cronstein: Inflammatory cytokines regulate function and expression of adenosine A (2A) receptors in human monocytic THP-1 cells. J Immunol 167, 4026-4032 (2001) (Pubitemid 32910848)
41. Nguyen D. Khoa, Carmen M. Montesinos, Adrienne J. Williams, Maureen Kelly and Bruce N. Cronstein: Th1 cytokines regulate adenosine receptors and their downstream signaling elements in human microvascular endothelial cells. J Immunol 171, 3991-3998 (2003) (Pubitemid 37238673)
42. Nguyen D. Khoa, Michael Postow, Jennifer Danielsson and Bruce N. Cronstein: Tumor necrosis factor-alpha prevents desensitization of Galphas-coupled receptors by regulating GRK2 association with the plasma membrane. Mol Pharmacol 69, 1311-1319 (2006)
43. Katia Varani, Alfonso Massara, Fabrizio Vincenzi, Alice Tosi, Melissa Padovan, Francesco Trotta and Pier Andrea Borea: Normalization of A2a and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor α but not methotrexate. Arthritis Rheum 60, 2880-2891 (2009)
44. S. Bar-Yehuda, L. Rath-Wolfson, L. Del Valle, A. Ochaion, S. Cohen, R. Patoka, G. Zozulya, F. Barer, E. Ata, S. Pina-Oviedo, G. Perez-Liz, D. Castel and P. Fishman: Induction of an antiinflammatory effect and prevention of cartilage damage in rat knee osteoarthritis by CF101 treatment. Arthritis Rheum 60, 3061-3071 (2009)
45. S. Shimegi: Mitogenic action of adenosine on osteoblast-like cells, MC3T3-E1. Calcif Tissue Int 62, 418-425 (1998) (Pubitemid 28180838)
46. S. Shimegi: ATP and adenosine act as a mitogen for osteoblast-like cells (MC3T3-E1). Calcif Tissue Int 58, 109-113 (1996) (Pubitemid 26049440)
47. Aisha V. Sauer, Emanuela Mrak, Raisa Jofra Hernandez, Elena Zacchi, Francesco Cavani, Miriam Casiraghi, Eyal Grunebaum, Chaim M. Roifman, Maria C. Cervi, Alessandro Ambrosi, Filippo Carlucci, Maria Grazia Roncarolo, Anna Villa, Alessandro Rubinacci, and Alessandro Aiuti: ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency. Blood 114, 3216-3226 (2009)
48. Michael S. Hershfield. Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy. Semin Hematol 35, 291-298 (1998) (Pubitemid 28477930)
49. Hiroshi Takayanagi, Sunhwa Kim, Takako Koga, Hiroshi Nishina, Masashi Isshiki, Hiroki Yoshida, Akio Saiura, Miho Isobe, Taeko Yokochi, Jun-ichiro Inoue, Erwin F. Wagner, Tak W. Mak, Tatsuhiko Kodama and Tadatsugu Taniguchi: Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3, 889-901 (2002) (Pubitemid 35460788)
50. Jeng-pyng Shaw, Paul J. Utz, David B. Durand, J. Jay Toole, Elizabeth Ann Emmel and Gerald R. Crabtree: Identification of a putative regulator of early T cell activation genes. Science 241, 202-205 (1988)
51. Nicole J. Horwood, Vicky Kartsogiannis, Julian M. W. Quinn, Evangelos Romas, T. John Martin and Matthew T. Gillespie: Activated T lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Commun 265, 144-150 (1999)
52. Silvia Colucci, Giacomina Brunetti, Rita Rizzi, Antonia Zonno, Giorgio Mori, Graziana Colaianni, Davide Del Prete, Roberta Faccio, Arcangelo Liso, Silvana Capalbo, Vincenzo Liso, Alberta Zallone, and Maria Grano: T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction Blood 104, 3722-3730 (2004) (Pubitemid 39564450)
53. Takako Koga, Masanori Inui, Kazuya Inoue, Sunhwa Kim, Ayako Suematsu, Eiji Kobayashi, Toshio Iwata, Hiroshi Ohnishi, Takashi Matozaki, Tatsuhiko Kodama, Tadatsugu Taniguchi, Hiroshi Takayanagi and Toshiyuki Takai: Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428, 758-763 (2004) (Pubitemid 38508286)
54. Attila Mócsai, Mary Beth Humphrey, Jessica A. G. Van Ziffle, Yongmei Hu, Andrew Burghardt, Steven C. Spusta, Sharmila Majumdar, Lewis L. Lanier, Clifford A. Lowell, and Mary C. Nakamura: The immunomodulatory adapter proteins DAP12 and Fc receptor γ-chain (FcRγ) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci U S A 101, 6158-6163 (2004) (Pubitemid 38520544)
55. Joan T. Merrill, Christine Shen, David Schreibman, Dan Coffey, Olga Zakharenko, Robert Fisher, Robert G. Lahita, Jane Salmon and Bruce N. Cronstein: Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritis. Arthritis Rheum 40, 1308-1315 (1997) (Pubitemid 27430143)
56. Fumio Yoshitake, Shousaku Itoh, Hiroko Narita, Katsuhiko Ishihara and Shigeyuki Ebisu: Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-κB signaling pathways. J Biol Chem 283, 11535-11540 (2008)
57. Ulf Lerner and Bertil B. Fredholm: 2-chloroadenosine increases calcium mobilization from mouse calvaria in vitro. Acta Endocrinol (Copenh) 100, 313-320 (1982) (Pubitemid 12069948)
58. Bruce N. Cronstein, Mark A. Eberle, Harry E. Gruber and Richard I. Levin: Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci USA 88, 2441-2445 (1991) (Pubitemid 21916433)
59. Hiroshi Asako, Robert E. Wolf and Neil D. Granger: Leukocyte adherence in rat mesenteric venules: effects of adenosine and methotrexate. Gastroenterology 104, 31-37 (1993) (Pubitemid 23040003)
60. Benoit Le Goff, Elise Soltner, Celine Charrier, Yves Maugars, Francoise Redini, Dominique Heymann and Jean-Marie Berthelot: A combination of methotrexate and zoledronic acid prevents bone erosins and systemic bone mass loss in collagen induced arthritis. Arthritis Res Ther 11, R185 (2009)
61. Vibeke Strand, Stanley Cohen, Michael Schiff, Arthur Weaver, Roy Fleischmann, Grant Cannon, Robert Fox, Larry Moreland, Nancy Olsen, Dan Furst, Jacque Caldwell, Jeffrey Kaine, John Sharp, Frank Hurley, Iris Loew-Friedrich: Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. Arch Intern Med 159, 2542-2550 (1999)
62. Axel Finckh, Julia F. Simard, Jeffrey Duryea, Matthew H. Liang, Jie Huang, Synove Daneel, Adrian Forster, Cem Gabay and Pierre-Andre Guerne: The effectiveness of antitumor necrosis factor therapy in preventing progressive radiographic joint damage in rheumatoid arthritis: a population-based study. Arthritis Rheum 54, 54-59 (2006) (Pubitemid 43122186)